Targeted Next-generation Sequencing

Targeted Next-Generation Sequencing is a high-throughput DNA sequencing methodology that selectively amplifies and analyzes specific genomic regions of interest, enabling sensitive detection of somatic mutations in circulating tumor DNA by enriching for cancer-related genes prior to sequencing.

2K

Publications

118.3K

Citations

19.1K

Authors

3.5K

Institutions

Publications per year

2017–2026

1.4K

Authors

19.1K

  1. MF
    Michael F. Berger

    Memorial Sloan Kettering Cancer Center, United States

    25 publications · 5.8K citations

    21

    h-index

  2. YS
    Yang Shao

    Nanjing Medical University, China

    23 publications · 2.2K citations

    19

    h-index

  3. SA
    Scott A. Tomlins

    University of Michigan, United States

    23 publications · 1.8K citations

    19

    h-index

  4. VE
    Volker Endris

    Heidelberg University, Germany

    19 publications · 913 citations

    19

    h-index

  5. AS
    Albrecht Stenzinger

    Heidelberg University, Germany

    21 publications · 925 citations

    19

    h-index

1–5 of 19.1K

Venues

  1. PLoS ONE

    90 publications · 4.2K citations

    39

    h-index

  2. Clinical Cancer Research

    52 publications · 6.9K citations

    38

    h-index

  3. Scientific Reports

    80 publications · 4.1K citations

    35

    h-index

  4. Oncotarget

    51 publications · 2.7K citations

    33

    h-index

  5. Journal of Molecular Diagnostics

    JMD · 32 publications · 2.3K citations

    25

    h-index

1–5